APLI (APLI) News
Follow APLI (APLI) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Appili Therapeutics Inc. (APLI) To Delist From TSX, Trade on NEX as APLI.H
Appili Therapeutics Inc. will voluntarily delist from the TSX on Oct 2, 2026 and commence trading on the NEX on Oct 5, 2026 with symbol APLI.H.Material DetailsContext by AI AnalystThis is a late-stage confirmation of lis
NEWS | Sep 29, 2026, 12:31 PM UTC
L
Appili Therapeutics Announces Transfer to NEX
Halifax, Nova Scotia--(. - September 29, 2026) - Appili Therapeutics Inc. TSX:APLI (OTC Pink: APLIF) (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases, announces
NEWS | Sep 29, 2026, 12:31 PM UTC
L
Appili Therapeutics Announces Receipt from NIAID of a Notice of Termination for Convenience on the Contract for the VXV-01 Program
HALIFAX, Nova Scotia, July 03, 2026 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: AP
EQUITY | Jul 03, 2026, 10:10 PM UTC